In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder

(2012) Hamid Afshar et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study

(2012) Ali Ghaleiha et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Treatment of Obsessive Compulsive Disorder

(2011) Martin E. Franklin et al.   Annual Review of Clinical Psychology

Neurobiology of obsessive–compulsive disorder: insights into neural circuitry dysfunction through mouse genetics

(2011) Jonathan T Ting et al.   CURRENT OPINION IN NEUROBIOLOGY

The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder

(2011) Ke Wu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder

(2010) S. Evelyn Stewart et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Memantine as an Augmenting Agent for Severe Pediatric OCD

(2009) DIANNE M. HEZEL et al.   AMERICAN JOURNAL OF PSYCHIATRY

Anterior Cingulate Glutamate–Glutamine Levels Predict Symptom Severity in Women With Obsessive–Compulsive Disorder

(2009) Murat Yücel et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity

(2008) Göran Starck et al.   JOURNAL OF NEURAL TRANSMISSION

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

(2008) A M Ruscio et al.   MOLECULAR PSYCHIATRY